PHAXIAM Therapeutics S.A. Net Asset Quality Index
PHAXIAM Therapeutics S.A. net asset quality index. PHAXIAM Therapeutics S.A. (PHXM) has a Net Asset Quality Index of 39.5% as of June 2024. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €39.11 Million minus total liabilities of €23.66 Million yields net assets of €15.45 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check earnings quality score of PHAXIAM Therapeutics S.A. to evaluate the quality of earnings relative to operating cash generation.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of PHAXIAM Therapeutics S.A. (2010–2023)
Net asset quality index of PHAXIAM Therapeutics S.A. from 2010 to 2023. This chart shows how PHAXIAM Therapeutics S.A.'s Net Asset Quality Index has evolved across 14 annual periods from 2010 to 2023. As of June 2024, the index stands at 39.5%, representing net assets of €15.45 Million against total assets of €39.11 Million EUR. See PHXM book value for net asset value and shareholders' equity analysis.
PHAXIAM Therapeutics S.A. Net Asset Quality Index by Year (2010–2023)
PHAXIAM Therapeutics S.A. net asset quality index by year from 2010 to 2023. The table below presents the year-by-year Net Asset Quality Index for PHAXIAM Therapeutics S.A. from 2010 to 2023, covering 14 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see PHXM company net worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2023 | 49.9% | €25.61 Million | €51.31 Million | €25.70 Million | ▼ -1.4 pp |
| 2022 | 51.3% | €23.49 Million | €45.81 Million | €22.32 Million | ▲ +17.1 pp |
| 2021 | 34.2% | €22.84 Million | €66.77 Million | €43.92 Million | ▲ +1.2 pp |
| 2020 | 33.0% | €26.54 Million | €80.40 Million | €53.86 Million | ▼ -39.2 pp |
| 2019 | 72.2% | €85.56 Million | €118.55 Million | €32.99 Million | ▼ -14.6 pp |
| 2018 | 86.8% | €145.60 Million | €167.84 Million | €22.24 Million | ▼ -6.2 pp |
| 2017 | 92.9% | €181.42 Million | €195.26 Million | €13.84 Million | ▲ +13.7 pp |
| 2016 | 79.3% | €35.64 Million | €44.97 Million | €9.33 Million | ▼ -9.7 pp |
| 2015 | 88.9% | €47.13 Million | €53.00 Million | €5.87 Million | ▲ +0.7 pp |
| 2014 | 88.2% | €35.82 Million | €40.61 Million | €4.78 Million | ▲ +12.5 pp |
| 2013 | 75.7% | €13.59 Million | €17.95 Million | €4.36 Million | ▲ +115.4 pp |
| 2012 | -39.7% | €-4.03 Million | €10.14 Million | €14.17 Million | ▼ -1.1 pp |
| 2011 | -38.6% | €-1.91 Million | €4.94 Million | €6.85 Million | ▼ -99.3 pp |
| 2010 | 60.7% | €3.99 Million | €6.56 Million | €2.58 Million | — |